Polyrizon files for U.S. patent application to expand IP moat around intranasal drug-delivery platform
PLRZ•Polyrizon filed a U.S. patent application to expand its intellectual property around its intranasal drug-delivery platform.
1. Patent application filed
Polyrizon said it filed a U.S. patent application to expand its IP moat around its intranasal drug-delivery platform.
